About the Company
checkpoint therapeutics, inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. the company's product candidates include ck-101 that in phase i clinical trial for the treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer; and cosibelimab, a programmed death ligand-1 (pd-l1), which is in phase i clinical trial in patients with selected recurrent or metastatic cancers. it also develops ck-103, a small molecule inhibitor of bet bromodomains; and ck-302, a human agonistic antibody for oncology indications. checkpoint therapeutics, inc. has collaboration agreements with tg therapeutics, inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. the company was founded in 2014 and is headquartered in new york, new york. checkpoint therapeutics, inc. is a subsidiary of fortr
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CKPT News
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
WALTHAM, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the ...
Checkpoint Therapeutics Inc CKPT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Checkpoint Therapeutics Inc (CZTA.SG)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
BMS Bails on Checkpoint Inhibitor Teaming with CytomX, Stock Sinks
Bristol Myers Squibb has pulled the plug on a more potent version of its cancer immunotherapy Yervoy. However, the two ...
Jail and cane for fugitive who crashed car into Tuas Checkpoint
High on drugs, a 48-year-old fugitive wanted in Singapore for drug offences crashed his car at Tuas Checkpoint in April 2022 ...
Land the size of over 60 football fields to be reclaimed to expand Woodlands Checkpoint
SINGAPORE - About 44ha of land will be reclaimed as part of works to expand the Woodlands Checkpoint - a smaller area than ...
S'pore-Johor bus driver, 45, jailed 3 weeks for running over legs of woman, 74, at Woodlands Checkpoint
A Singapore-Johor bus driver who ran over the legs of an elderly woman at Woodlands Checkpoint was sentenced to three weeks ...
Obsidian Therapeutics Announces Clinical & Preclinical Presentations at the American Association of Cancer Research Annual Meeting
March 05, 2024--(BUSINESS WIRE)--Obsidian Therapeutics, Inc., a clinical ... that has relapsed and/or is refractory to prior immune checkpoint inhibitor (ICI) therapy (NCT05470283).
Checkpoint Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
JTC to reclaim over 60 football fields of land to expand Woodlands Checkpoint
About 44ha of land – the size of more than 60 football fields – will be reclaimed as part of the expansion of Woodlands ...
Loading the latest forecasts...